Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Dapagliflozin
61%
Insulin
22%
Glucagon
16%
Fatty Acid
11%
Exendin 4
11%
Hormone
5%
Hydroxybutyric Acid
5%
Non Insulin Dependent Diabetes Mellitus
5%
Glucose
5%
Creatinine
5%
Glucosuria
5%
Drug
5%
Glycerol
5%
Hemoglobin A1c
5%
Ketoacidosis
5%
Clotiazepam
5%
Medicine and Dentistry
Dapagliflozin
61%
Glucagon
16%
Plasma
16%
Fatty Acid
11%
Hematocrit
11%
Exenatide
11%
Drug Combination
11%
Patient
11%
Inpatient
11%
Urine
5%
Metabolite
5%
Glucose
5%
Body Weight
5%
Hemoglobin A1c
5%
Maturity Onset Diabetes of the Young
5%
Patient with Type 2 Diabetes
5%
Hormone
5%
Creatinine
5%
Glycon
5%
Hydroxybutyric Acid
5%
Ketoacidosis
5%
Glycerol
5%
Glucosuria
5%
Drug
5%
Chemotherapeutic Agent
5%
Meal
5%
Clotiazepam
5%
Combined Therapy
5%
Biochemistry, Genetics and Molecular Biology
Dapagliflozin
61%
Insulin
11%
Insulin Blood Level
11%
Hematocrit
11%
Glucagon
11%
Body Weight
5%
Fatty Acid Blood Level
5%
Creatinine
5%
Glucagon Blood Level
5%
Glucose Urine Level
5%
Free Fatty Acids
5%
Glycerol
5%
Veterinary Science and Veterinary Medicine
Glucagon
16%
Creatinine
5%
Ketoacidosis
5%
Glycosuria
5%